Facebook link Linked In link You Tube link

FOCIS 2012

FOCIS 2012 | Photo Gallery | CME / Certification of Attendance | Abstracts | Supporters

Download the 2012 Scientific Program

FOCIS is the leading collaborative forum for education, research and networking across the broad field of clinical immunology. Please join us as we explore the various immunologic issues that bind our community.   

Since its conception in 2001, the FOCIS organization has grown to 52 Member Societies that collectively represent over 65,000 basic and clinician scientists. Each year, the FOCIS meeting brings together these researchers and clinicians from around the world, working in more than 30 clinical specialties and provides them with a forum to gather and share the latest findings, breakthroughs and therapies related to human disease. The FOCIS concept posits that interrelationships between fields sharing clinical immunology expertise will build a better and faster pathway to improve knowledge that leads to new therapies for inflammatory and immunologic diseases.

World-renowned speakers in the field of clinical immunology will explore their work and touch on the five themes embraced by FOCIS: Immunoregulation, Immunodiagnosis, Immunogenetics, Immunotherapy and Host Defense.

Continuing Medical Education (CME)
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the Federation of Clinical Immunology Societies. The Federation of Clinical Immunology Societies is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education credits for physicians.
 
The Federation of Clinical Immunology Societies designates this live activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Meeting Location
Vancouver Convention Centre East
999 Canada Place
Vancouver, BC, V6C 0C3, Canada 

Share